Literature DB >> 33463195

Antimicrobial Bioresorbable Mg-Zn-Ca Alloy for Bone Repair in a Comparison Study with Mg-Zn-Sr Alloy and Pure Mg.

Chaoxing Zhang1,2, Jiajia Lin1,2, Nhu-Y Thi Nguyen3, Yuxing Guo4, Changlu Xu1,2, Catherine Seo2, Edgar Villafana2, Hector Jimenez2, Yang Chai4, Renguo Guan5, Huinan Liu1,2,3,6,7.   

Abstract

Magnesium-zinc-calcium (Mg-Zn-Ca) alloys have attracted increasing attention for biomedical implant applications, especially for bone repair, because of their biocompatibility, biodegradability, and similar mechanical properties to human bone. The objectives of this study were to characterize Mg-2 wt % Zn-0.5 wt % Ca (named ZC21) alloy pins microstructurally and mechanically, and determine their degradation and interactions with host cells and pathogenic bacteria in vitro and in vivo in comparison with the previously studied Mg-4 wt % Zn-1 wt % strontium (named ZSr41) alloy and Mg control. Specifically, the in vitro degradation and cytocompatibility of ZC21 pins with bone marrow derived mesenchymal stem cells (BMSCs) were investigated using both direct culture and direct exposure culture methods. The adhesion density of BMSCs on ZC21 pins (i.e., direct contact) was significantly higher than on pure Mg pins in both in vitro culture methods; the cell adhesion density around ZC21 pins (i.e., indirect contact) was similar to the cell-only positive control in both in vitro culture methods. Interestingly, ZC21 showed a higher daily degradation rate, crack width and crack area ratio in the direct exposure culture than in the direct culture, suggesting different culture methods did affect its in vitro degradation behaviors. When cultured with Gram-positive bacteria methicillin-resistant Staphylococcus aureus (MRSA), ZC21 reduced bacterial adhesion on the surface more significantly than that of ZSr41 and Mg. The in vivo degradation and biocompatibility of the ZC21 pins for bone regeneration were studied in a mouse femoral defect model. The in vivo degradation rate of ZC21 pins was much slower than that of ZSr41 alloy and Mg control pins. After 12 weeks of implantation in vivo, the ZC21 group showed the shortest gap at the femoral defect, indicating that ZC21 pins promoted osteogenesis and bone healing more than ZSr41 and Mg control pins. Overall, the ZC21 alloy is promising for bone repair, while providing antibacterial activities, and should be further studied toward clinical translation.

Entities:  

Keywords:  antimicrobial properties; biocompatibility; biodegradable alloys; bioresorbable pins and wires for medical implants; cytocompatibility with bone marrow derived mesenchymal stem cells (BMSCs); degradation; magnesium−zinc−calcium (Mg−Zn−Ca); magnesium−zinc−strontium (Mg−Zn−Sr); methicillin-resistant Staphylococcus aureus (MRSA); mouse femoral defect model in vivo

Mesh:

Substances:

Year:  2019        PMID: 33463195     DOI: 10.1021/acsbiomaterials.9b00903

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  4 in total

Review 1.  Mg-, Zn-, and Fe-Based Alloys With Antibacterial Properties as Orthopedic Implant Materials.

Authors:  Ning Wang; Yutong Ma; Huixin Shi; Yiping Song; Shu Guo; Shude Yang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-23

2.  In vivo performance of a rare earth free Mg-Zn-Ca alloy manufactured using twin roll casting for potential applications in the cranial and maxillofacial fixation devices.

Authors:  Matthew S Dargusch; Nagasivamuni Balasubramani; Nan Yang; Sean Johnston; Yahia Ali; Gui Wang; Jeffrey Venezuela; Jiwon Carluccio; Cora Lau; Rachel Allavena; Daniel Liang; Karine Mardon; Qingsong Ye
Journal:  Bioact Mater       Date:  2021-10-23

Review 3.  Sequence Does Not Matter: The Biomedical Applications of DNA-Based Coatings and Cores.

Authors:  Svetlana Batasheva; Rawil Fakhrullin
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

Review 4.  Recent Advances in Research on Antibacterial Metals and Alloys as Implant Materials.

Authors:  Juyang Jiao; Shutao Zhang; Xinhua Qu; Bing Yue
Journal:  Front Cell Infect Microbiol       Date:  2021-07-02       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.